ZIOP Financial Facts

Research contract revenue: 1.6M
Total operating expenses: 12.51M
See Full Income Statement

Total liabilities: 59.73M
Deferred revenue - current portion: 6.39M
See Full Balance Sheet

ZIOPHARM (ZIOP) Earnings

  |   Expand Research on ZIOP
Next EPS Date 8/6/21 *Est. EPS Growth Rate -11.1% *Last Qtr.
Average EPS % Beat Rate -5.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/21 Q121 -$0.10-$0.10 $0.00N/AN/A N/A Details
2/25/21 Q420 -$0.11-$0.10 -$0.01N/AN/A N/A Details
11/5/20 Q320 -$0.10-$0.09 -$0.01N/AN/A N/A Details
8/6/20 Q220 -$0.09-$0.09 $0.00N/AN/A N/A Details
5/7/20 Q120 -$0.09-$0.08 -$0.01N/AN/A N/A Details
3/2/20 Q419 -$0.09-$0.08 -$0.01N/AN/A N/A Details
11/7/19 Q319 -$0.43-$0.09 -$0.34N/AN/A N/A Details
3/1/18 Q417 -$0.13-$0.14 +$0.01$1.6M$1.59M = Details